Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: ADEL 7 who wrote (32)	11/3/1998 10:42:00 AM
From: Ariella	Respond to of 1386

Conference call today at 4 p.m. EST Call about 10 minutes ahead: 1-800-289-0730

To: ADEL 7 who wrote (32)	11/3/1998 10:46:00 AM
From: David Israel-Rosen	Read Replies (1) \| Respond to of 1386

Congratulation to PARs Management are in order: Again, PARS Mgt managed to HIDE the Success of Clinical Trial and the rest of the pipe line in the last Paragraph of the Press Release... ...The part that DowJones Service DOES NOT POST on the DOWJONES MONITORS. If you have a DowJones Monitor all YOU CAN SEE is that Revenues were down...You will not even know that the two drugs being sold have about 5% market share and growing... For the life of me, I do not understand why PARs could not issue three press releases like the rest of the world will do. One - Results TWO- Market Share 5% and Growing rapidly Three - Pipe Line Update. THis is not rocket science IT IS BASIC. It about time that the members of this thread Urge Mgt to shape up it PR !!! Any one would like to defend MGT ? What are they waiting for ? for some Group to Build a Control Stake (~10% and Sell PARs for a quick profit ? If you think that this is impossible go check BTGC they had to put a Defense to prevent that from happening to them !!! David